Table 2 –
Rejection Outcomes
| Total Cohort | Propensity-Matched Cohort | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| DBD | DCD | p | DBD | DCD | p | |
| n | 5582 | 292 | 358 | 152 | ||
| PRA >10% (%) | 869 (21.3) | 38 (15.3) | 0.031 | 41 (15.7) | 19 (13.1) | 0.574 |
| Peak PRA >10% (%) | 1127 (27.6) | 52 (21.0) | 0.027 | 58 (22.3) | 28 (19.3) | 0.562 |
| Acute rejection prior to discharge (%) | 1027 (18.4) | 68 (23.3) | 0.044 | 48 (13.4) | 26 (17.1) | 0.344 |
| Treated for acute rejection prior to discharge (%) | 543 (9.7) | 38 (13.0) | 0.083 | 23 (6.4) | 17 (11.2) | 0.099 |
| Treated for rejection within 1 year (%) | 564 (10.1) | 38 (13.0) | 0.134 | 22 (6.1) | 19 (12.5) | 0.025 |
| Hospitalized for rejection (%) | 230 (11.4) | 18 (23.4) | 0.003 | 9 (8.7) | 12 (27.3) | 0.007 |
| Follow-up time (months) for hospitalization for rejection (mean (SD)) | 14.56 (5.76) | 14.98 (6.04) | 0.529 | 14.25 (5.90) | 14.91 (5.66) | 0.531 |
| Hospitalized for infection (%) | 754 (37.5) | 33 (42.9) | 0.401 | 44 (42.3) | 18 (40.9) | 1.000 |
| Follow-up time (months) for hospitalization for infection (mean (SD)) | 14.56 (5.76) | 14.98 (6.04) | 0.522 | 14.25 (5.90) | 14.91 (5.66) | 0.531 |
| Coronary vasculopathy (%) | 257 (6.8) | 11 (6.3) | 0.926 | 11 (5.4) | 8 (9.1) | 0.365 |
| Follow-up time (months) for coronary vasculopathy (mean (SD)) | 15.41 (5.88) | 14.15 (5.38) | 0.006 | 14.06 (5.58) | 13.98 (5.41) | 0.913 |